Alvotech ( ALVO) - Key Metrics
ALVO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.38 | -$0.02 | -$0.19 | -$0.25 |
| 2025Q2 | $0.62 | $0.11 | $0.20 | $0.15 |
| 2025Q1 | $0.47 | $0.39 | $0.04 | -$0.04 |
| 2024Q4 | $0.50 | -$0.22 | -$0.13 | -$0.23 |
ALVO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -117.81 |
| 2025Q2 | ? | 20.01 |
| 2025Q1 | ? | 6.20 |
| 2024Q4 | ? | -14.91 |
ALVO
Price: $3.52
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 35.50
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 billion